UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE

UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE

Abstract Large placebo-controlled trials have demonstrated kidney and cardiovascular clinical benefits of SGLT-2 inhibitors. Data from the EMPA-KIDNEY and DELIVER trials and associated meta-analyses triggered an update to the UK Kidney Association Clinical Practice Guideline on Sodium-Glucose Co-tra...

Full description

Bibliographic Details
Main Authors: Alistair J. Roddick, Alexa Wonnacott, David Webb, Angela Watt, Michael A. Watson, Natalie Staplin, Alex Riding, Eirini Lioudaki, Apexa Kuverji, Mohsen El Kossi, Patrick Holmes, Matt Holloway, Donald Fraser, Chris Carvalho, James O. Burton, Sunil Bhandari, William G. Herrington, Andrew H. Frankel
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Nephrology
Subjects:
Guideline
Chronic kidney disease
Acute kidney injury
Gliflozin
Online Access:https://doi.org/10.1186/s12882-023-03339-3

Internet

https://doi.org/10.1186/s12882-023-03339-3

Similar Items